Faisal Mehmud - Dec 31, 2024 Form 3 Insider Report for Medicus Pharma Ltd. (MDCX)

Role
Chief Medical Officer
Signature
/s/ James Quinlan, as Attorney-in-Fact, for Faisal Mehmud
Stock symbol
MDCX
Transactions as of
Dec 31, 2024
Transactions value $
$0
Form type
3
Date filed
12/31/2024, 04:16 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDCX Stock Option (right to buy) Dec 31, 2024 Common Shares 100K $2.26 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option has vested and is exercisable as of the date hereof.
F2 Represents an exercise price of $3.25 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney